APOE and Parkinson disease: We hypothesize that both dementia4 and mortality in PD are largely driven by amyloid-β pathology and plaque formation influenced by APOE ε4 genotype, although APOE may also contribute via other mechanisms such as immune responses18 and Lewy body pathology29,30.